Skip to main content
. 2015 Jul;21(7):1174–1182. doi: 10.3201/eid2107.141748

Table 1. Description of studies included in analysis of hepatitis virus seroprevalence, Malawi, 1989–2008*.

Study name, period (reference) Study site/setting Study type Study population HIV status Aims of study
ICAR,1989–1994 (21,22) Queen Elizabeth Central Hospital, Blantyre/urban Observational cohort Pregnant and postpartum women +/– Assess adverse pregnancy outcomes and rates of mother-to-child transmission of HIV
SUCOMA, 1998 (23) Nchalo District, sugar estate/rural, occupational Observational survey Adult men +/– Identify epidemiologic and biologic determinants of HIV infection in an occupational male cohort
NVAZ, 2000–2004 (24) Queen Elizabeth Central Hospital, Blantyre/urban Randomized clinical trial Pregnant women + Assess efficacy of short antiretroviral post-exposure prophylaxis to prevent mother to child transmission of HIV
MWANZA, 2001 (T.E. Taha, unpub. data) Mwanza District/rural Observational survey Adult men and women +/– Assess risk factors associated with prevalent HIV infection in a rural area adjacent to the borders with Mozambique
METRO, 2003–2005 (25) Queen Elizabeth Central Hospital; health centers in Blantyre/urban Randomized clinical trial Adult women (nonpregnant) +/– Assess the efficacy of intermittent intravaginal metronidazole gel use in reducing bacterial vaginosis infection
PEPI, 2004–2008 (26) Queen Elizabeth Central Hospital; health centers in Blantyre/urban Randomized clinical trial Pregnant women + Assess efficacy of extended antiretroviral postexposure prophylaxis to prevent mother to child transmission of HIV

*ICAR, International Collaborations on AIDS Research; SUCOMA, a study of prevalence among male workers for the Sugar Company of Malawi; NVAZ, a study of efficacy of nevirapine/zidovudinel postexposure prophylaxis to prevent mother-to-child transmission of HIV; MWANZA, a study of risk factors associated with prevalent HIV infection in the rural town of Malawi; METRO, a study in which efficacy of intravaginal metronidazole gel in reducing bacterial vaginosis was assessed; PEPI, a study of antiretroviral postexposure prophylaxis to prevent mother to child transmission of HIV.